SOURCE: BioProgress PLC

July 27, 2005 06:10 ET

BioProgress PLC announces Issue of Equity

Cambridgeshire -- (MARKET WIRE) -- July 27, 2005 --

BioProgress plc

("BioProgress" or "the Company")

Issue of Equity

BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the provider of innovative delivery mechanisms for the pharmaceutical oral dosage markets, announces that as part of a settlement of the claim brought by Mr Charles Tatnall against the Company or its operations, as referred to in the AGM statement on 22 June 2005, 992,908 ordinary shares of 1p each have been issued to Mr Tatnall. Application will be made for these 992,908 ordinary shares of 1p each being admitted to trading on AIM. Admission of these new ordinary shares is expected to be effective on 28 July 2005.

27 July 2005


BioProgress plc                                           01354 655674
Richard Trevillion, Chief Executive Officer
Dan Farrow, Finance Director

College Hill                                             020 7457 2020
Adrian Duffield/Corinna Dorward

Forward-Looking Information.

The Ordinary Shares of BioProgress plc are registered under the US Securities and Exchange Act of 1934. To the extent that this announcement contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, this paragraph applies. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements in this release include statements addressing future financial and operating results and the timing and benefits of the reorganisation. Detailed information about factors pertinent to the business of the company that could cause actual results to differ is set forth in the Company's filings with the Securities and Exchange Commission. The Company is under no obligation to (and expressly disclaim any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise. This announcement is for information only and does not constitute an offer or invitation to acquire or dispose of any securities or investment advice. The distribution of the announcement and/or issue of securities in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe such restrictions.

                      This information is provided by RNS
            The company news service from the London Stock Exchange